Literature DB >> 7683693

Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.

L X Fu1, Y Magnusson, C H Bergh, J A Liljeqvist, F Waagstein, A Hjalmarson, J Hoebeke.   

Abstract

A peptide corresponding to the sequence 169-193 of the second extracellular loop of the human muscarinic acetylcholine receptor-2 was used as an antigen to screen sera from patients with idiopathic dilated cardiomyopathy (DCM, n = 36) and healthy blood donors (HBD, n = 40). The sera from 14 patients with DCM (38.8%) and 3 HBD (7.5%) recognized the muscarinic receptor peptide at dilutions varying from 1:20 to 1:160 in ELISA. A highly significant correlation (P = 0.006) was found between the presence of antimuscarinic receptor-2 autoantibodies and anti-beta-adrenoceptor-1 autoantibodies in the patients' sera. Affinity-purified autoantibodies from positive sera of patients with DCM recognized on the electrotransferred protein of rat ventricular membrane a major band of about 80 kD. Incubation of autoantibodies with membrane resulted not only in a decrease in the maximal binding sites (Bmax) but also in an increase in Kd of radioligand binding in a concentration-dependent manner. This suggests a mixed-type of inhibition. Moreover, preincubation with atropine abolished the inhibitory effect of autoantibodies on the receptor binding whereas carbachol appeared to have no effect on the activity of the autoantibodies. These data define a subgroup of patients with idiopathic DCM who have in their sera functionally active autoantibodies against muscarinic receptor-2.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683693      PMCID: PMC288192          DOI: 10.1172/JCI116416

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Primary structure and biochemical properties of an M2 muscarinic receptor.

Authors:  E G Peralta; J W Winslow; G L Peterson; D H Smith; A Ashkenazi; J Ramachandran; M I Schimerlik; D J Capon
Journal:  Science       Date:  1987-05-01       Impact factor: 47.728

2.  Antibodies against heart muscle and nuclear constituents in cardiomyopathy.

Authors:  S K Das; J T Cassidy; R E Petty
Journal:  Am Heart J       Date:  1972-02       Impact factor: 4.749

3.  Beta-blocking autoantibodies in pediatric bronchial asthma.

Authors:  M Blecher; S Lewis; J M Hicks; S Josephs
Journal:  J Allergy Clin Immunol       Date:  1984-09       Impact factor: 10.793

4.  The antigenic characteristics and the significance of the adenine nucleotide translocator as a major autoantigen to antimitochondrial antibodies in dilated cardiomyopathy.

Authors:  H P Schultheiss; P Schwimmbeck; H D Bolte; M Klingenberg
Journal:  Adv Myocardiol       Date:  1985

5.  Mechanisms in cardiomyopathies.

Authors:  J F Goodwin
Journal:  J Mol Cell Cardiol       Date:  1985-07       Impact factor: 5.000

6.  A circulating IgG in Chagas' disease which binds to beta-adrenoceptors of myocardium and modulates their activity.

Authors:  E Borda; J Pascual; P Cossio; M De La Vega; R Arana; L Sterin-Borda
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

7.  Beta 2-adrenergic receptor antibodies in myasthenia gravis.

Authors:  H Eng; Y Magnusson; G Matell; A K Lefvert; R Saponja; J Hoebeke
Journal:  J Autoimmun       Date:  1992-04       Impact factor: 7.094

8.  Autoantibodies to beta 2-adrenergic receptors: a possible cause of adrenergic hyporesponsiveness in allergic rhinitis and asthma.

Authors:  J C Venter; C M Fraser; L C Harrison
Journal:  Science       Date:  1980-03-21       Impact factor: 47.728

9.  Monoclonal antibodies against the native or denatured forms of muscarinic acetylcholine receptors.

Authors:  C André; J G Guillet; J P De Backer; P Vanderheyden; J Hoebeke; A D Strosberg
Journal:  EMBO J       Date:  1984-01       Impact factor: 11.598

10.  Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis.

Authors:  L J Wolfgram; K W Beisel; N R Rose
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  58 in total

Review 1.  Chagas' disease and the autoimmunity hypothesis.

Authors:  F Kierszenbaum
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Role of muscarinic receptors in the regulation of immune and inflammatory responses.

Authors:  Seddigheh Razani-Boroujerdi; Muskaan Behl; Fletcher F Hahn; Juan Carlos Pena-Philippides; Julie Hutt; Mohan L Sopori
Journal:  J Neuroimmunol       Date:  2008-01-10       Impact factor: 3.478

3.  Foreword to special issue on "Myocarditis".

Authors:  Alida L P Caforio
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

4.  Phenotype of early cardiomyopathic changes induced by active immunization of rats with a synthetic peptide corresponding to the second extracellular loop of the human beta-adrenergic receptor.

Authors:  L Buvall; E Bollano; J Chen; W Shultze; M Fu
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

5.  Pathophysiological role of autoantibodies against G-protein-coupled receptors in the cardiovascular system.

Authors:  Wolfgang Schulze; Rudolf Kunze; Gerd Wallukat
Journal:  Exp Clin Cardiol       Date:  2005

Review 6.  Unresolved issues in theories of autoimmune disease using myocarditis as a framework.

Authors:  Robert Root-Bernstein; DeLisa Fairweather
Journal:  J Theor Biol       Date:  2014-12-04       Impact factor: 2.691

Review 7.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

8.  Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism.

Authors:  Stavros Stavrakis; Xichun Yu; Eugene Patterson; Shijun Huang; Sean R Hamlett; Laura Chalmers; Reji Pappy; Madeleine W Cunningham; Syed A Morshed; Terry F Davies; Ralph Lazzara; David C Kem
Journal:  J Am Coll Cardiol       Date:  2009-09-29       Impact factor: 24.094

Review 9.  Cardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure.

Authors:  Ziya Kaya; Hugo A Katus; Noel R Rose
Journal:  Clin Immunol       Date:  2009-05-14       Impact factor: 3.969

10.  Opposing cardiac effects of autoantibody activation of β-adrenergic and M2 muscarinic receptors in cardiac-related diseases.

Authors:  Stavros Stavrakis; David C Kem; Eugene Patterson; Pedro Lozano; Shijun Huang; Bela Szabo; Madeleine W Cunningham; Ralph Lazzara; Xichun Yu
Journal:  Int J Cardiol       Date:  2010-01-06       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.